Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis - Wikidata - wikimedia - TriplyDB

Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis

Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis

http://www.wikidata.org/entity/Q37039809

about

HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma New advances in hepatocellular carcinoma Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.Prevention of portal hypertension: from variceal development to clinical decompensation Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy.Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study Invasive and non-invasive diagnosis of cirrhosis and portal hypertension What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.Platelet-related phenotypic patterns in hepatocellular carcinoma patients.Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases.Recent advances in the management of variceal bleeding Diagnostic Imaging of Hepatocellular Carcinoma - A Pictorial Essay.Treatment of portal hypertension Clinical pharmacology of portal hypertension.Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis.Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.Elevated levels of endothelin-1 in hepatic venous blood are associated with intrapulmonary vasodilatation in humans.Portal hypertensive gastropathy as a prognostic index in patients with liver cirrhosis.After proper optimization of carvedilol dose, do different child classes of liver disease differ in terms of dose tolerance and response on a chronic basis?Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.Quantitative histological-hemodynamic correlations in cirrhosis.Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt.Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging.Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension.Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.Hepatic venous pressure gradient: clinical use in chronic liver disease.Cardiovascular changes in cirrhosis: pathogenesis and clinical implications.Indications for portal pressure measurement in chronic liver disease.Potential for statins in the chemoprevention and management of hepatocellular carcinoma.Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.Natural history of cirrhosis.Assessing portal hypertension in liver diseases.

P2860

Q26738597-7B5C0FBB-7FE0-4647-B371-4ED45947A9A3 Q26749329-E72A5981-BFB6-4D4C-B56D-D73A9C420501 Q26853160-EE88B77C-4508-4673-B469-D08A67EFEA47 Q26865665-D6A27397-9B4B-4C60-A4EB-530FF7749FBF Q27013775-FD7C70D1-4F7B-4E29-9F7B-FBDCA177AE17 Q28272678-56422F6C-A4DF-481B-BFE7-FF5973083636 Q30355947-3D692570-E35B-4E25-B0B5-B5AAAD65FE1F Q30395363-EBBBAD6B-185E-453C-B092-307082BC1A43 Q30439743-BC39252B-CFFA-405D-A19F-D7F1A819831A Q30908529-DF1ED1D9-DBD3-494C-8A65-D338C5C327BF Q33410073-56968B62-FFEE-4803-A02F-3728EE83687C Q33416416-24BB8803-207C-4B30-8C6E-2EB57E8ACE54 Q33555680-95A6FB3C-F490-41D3-BEA5-2C2B0E7650A0 Q33647530-42648D21-A4FC-41B8-902A-A2950A4821D2 Q33668652-8B4FAE64-BE4C-48BB-9693-BDE05BA81006 Q34265176-0C19C3EA-22A7-40CB-A06D-BABC579F7128 Q34399357-E61E8B6C-C535-4E25-92EB-DA14D7C05AF7 Q34671935-2707C221-86C7-4598-B3D1-AC45172999EF Q35169410-5EFEC40E-48A0-44C0-ADB2-C3939100C817 Q35237338-1D743D38-50A5-4F8B-A05A-FBA4F56F48EC Q35590977-850510A6-1991-478E-974F-7C5EDC3B772C Q35928746-B190C332-258C-428C-A4BD-A4D1F722F412 Q35991529-323FC990-93BB-4F1D-8B3F-F90348A82D36 Q36103098-DCB268E2-6D8E-4CF6-A40D-B6B542672493 Q36246310-D1BD6AD8-ADF5-410A-ACEB-38AAFF658D46 Q36682618-CB33717B-6A37-44FA-BF23-E3DDB24E1EEB Q36987260-E634724D-A670-40F0-9C11-A0E6300B1939 Q37019451-4910885B-2D4D-4502-AD64-2A21AEDAEDDA Q37039936-D0C41B8B-019E-4D86-AEB0-EE88E947EA23 Q37408313-D9D7E1EA-1DB2-42C0-AA2E-8156890D5DB8 Q37441985-507008DD-327E-4906-9622-FEB874930698 Q37651909-F6D63EFC-E1AB-4518-97E4-E056F7E64B83 Q37676132-6805F5D3-3256-428F-A210-9469ED0EEEB4 Q37711328-B3551697-AF80-42D6-955F-2B40DAAC51DF Q37771146-85D75FBF-7F78-49D7-A802-40B100F72AA2 Q38027225-2FC3005C-114A-4045-B616-BB078009E046 Q38030991-9B0601FC-86AE-42DC-9EBD-0DE6E8B64F17 Q38046452-852F947F-18B3-499F-9442-D3191A856BAD Q38073661-192F1011-ECE0-483C-8E24-275AD6FCD227 Q38077823-62C1E625-03A6-4648-8E16-2166A2EB93CF

P2860

Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis

http://www.wikidata.org/entity/Q37039809

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hepatic venous pressure gradie ...... ently of severity of cirrhosis

@en

Hepatic venous pressure gradie ...... ntly of severity of cirrhosis.

@nl

type

label

Hepatic venous pressure gradie ...... ently of severity of cirrhosis

@en

Hepatic venous pressure gradie ...... ntly of severity of cirrhosis.

@nl

prefLabel

Hepatic venous pressure gradie ...... ently of severity of cirrhosis

@en

Hepatic venous pressure gradie ...... ntly of severity of cirrhosis.

@nl

P1433

Q37039809-BB99184A-76EA-4E8C-B051-EE98FDE8FDFC

P1476

Q37039809-FF39A7C3-5315-495D-A748-1DBC5EF148E5

P2093

Q37039809-0CAB41CA-E5E8-4701-BE62-45D0E24F9CE8

Q37039809-2872AF17-E83E-40F6-88CB-A30673A90747

Q37039809-2A1DDAE5-40FA-47EF-AEDE-345A579A01DE

Q37039809-45DC0126-BD76-4C56-A513-3C400583F9FD

Q37039809-48DC270D-AF04-473B-A575-99E85B032668

Q37039809-6F9DFEBF-997E-4C0E-AB88-991740E26236

Q37039809-895ED7CD-29EB-4813-AB25-73B0D8386D12

Q37039809-8EC85F3F-9955-406D-B176-4CF6AA6E1F54

Q37039809-A938FC2D-9EBF-4E6A-A589-F1E64F60FF9B

Q37039809-B59D0EF9-CCF5-4474-92E9-34C138FB9346

P2860

Q37039809-02714844-141F-4EB8-A762-6878B95EA38F

Q37039809-1113BD99-64E1-4935-A956-B60EA4C45504

Q37039809-15BD246C-76CA-49C1-9B9E-180D27B99C0B

Q37039809-3B7374E7-1C8D-4C6C-859A-A4D94DE98E41

Q37039809-50E03797-EC28-4ABC-A634-8B3D45A63AA1

Q37039809-55225076-5AD1-48E3-A86E-A603E2972106

Q37039809-5751F95B-E956-4CAA-AB3B-AA4F8E76685D

Q37039809-68EDC476-9219-4C75-BF35-1DDA3CF260C2

Q37039809-69A8BED9-7B87-4A5A-9DA4-FB9684584E83

Q37039809-6F5E4A4E-60D7-4752-BC44-BEFC2BDEC66A

P304

Q37039809-7A61E6CB-5A43-467B-8EA1-621904E1E7DC

P31

Q37039809-4C293683-49F4-4B32-88F3-0655749CC30C

P356

Q37039809-D042EEB5-74D1-4BD8-A012-0794333EBE5F

P433

Q37039809-0CB296C1-0FCF-46D2-BF13-2D307F31B0AC

P478

Q37039809-B3857746-3469-4F37-BD86-E310CF51A5A5

P50

Q37039809-6D99A840-8AC1-4EBF-9AEC-05970839D82E

P577

Q37039809-CDFA8337-F2AD-4EDA-BBDE-287F17F16F12

P5875

Q37039809-BE6E456E-2738-4925-8561-26F2BC415DC5

P698

Q37039809-CC0F5735-F90E-4039-BDE9-02F31A146E20

P921

Q37039809-ED8A242F-CB07-427E-BB44-2DFDB5BFCDF9

P932

Q37039809-947BED1F-4C53-4E08-AB2C-49729CC5BDE5

P356

J.JHEP.2009.01.014

P1433

Journal of Hepatology

P1476

Hepatic venous pressure gradie ...... ently of severity of cirrhosis

@en

P2093

Angels Escorsell

http://www.w3.org/2001/XMLSchema#string

Cristina Ripoll

http://www.w3.org/2001/XMLSchema#string

Daniel S Matloff

http://www.w3.org/2001/XMLSchema#string

David Patch

http://www.w3.org/2001/XMLSchema#string

Guadalupe Garcia-Tsao

http://www.w3.org/2001/XMLSchema#string

Jaime Bosch

http://www.w3.org/2001/XMLSchema#string

Juan Carlos Garcia-Pagan

http://www.w3.org/2001/XMLSchema#string

Norman Grace

http://www.w3.org/2001/XMLSchema#string

Portal Hypertension Collaborative Group

http://www.w3.org/2001/XMLSchema#string

Ramon Planas

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

Inflammation and cancer: the role of the immune response and angiogenesis.

Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

Randomized controlled trial of screening for hepatocellular carcinoma.

P304

923-928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2009.01.014

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Andrew K Burroughs

P577

2009-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24216777

http://www.w3.org/2001/XMLSchema#string

P698

19303163

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

3721146

http://www.w3.org/2001/XMLSchema#string